[ad_1] Here are some of the biggest movers of Monday. Stock gainers: Biogen Inc. shares…
Tag:
Product/Service Approvals
-
-
STOCK MARKET
FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment
by userby user[ad_1] Advisers to the U.S. Food and Drug Administration on Friday voted unanimously in favor…
-
STOCK MARKET
Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
by userby user[ad_1] Eisai shares 4523, +8.77% rose sharply Thursday morning after the U.S. Food and Drug…
-
[ad_1] Medicare on Thursday announced plans for coverage of new Alzheimer’s drugs whose accessibility has…
-
STOCK MARKET
Elon Musk’s Neuralink says it has FDA approval for first human clinical study
by userby user[ad_1] Elon Musk’s Neuralink said Thursday it has received regulatory approval to start the first…
-
[ad_1] The Food and Drug Administration said Tuesday that it approved Innoviva’s INVA, -0.73% Xacduro…
-
[ad_1] Advisers to the U.S. Food and Drug Administration voted Thursday in favor of Pfizer’s…
-
STOCK MARKET
FDA advisers narrowly back accelerated approval of Sarepta gene therapy
by userby user[ad_1] U.S. Food and Drug Administration advisers voted 8-6 Friday to recommend the agency grant…
-
STOCK MARKET
Opioid overdose antidote Narcan will be available over-the-counter by late summer after FDA approval
by userby user[ad_1] Emergent BioSolutions Inc. announced Wednesday that the U.S. Food and Drug Administration approved its…
-
STOCK MARKET
Veterans Health Administration will cover new Alzheimer’s drug. Why won’t Medicare?
by userby user[ad_1] The Center for Medicaid and Medicare Services and its chief administrator, Chiquita Brooks-LaSure, look…